PCS
TMO icon

Personal CFO Solutions’s Thermo Fisher Scientific TMO Stock Holding History

Personal CFO Solutions’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
2,112
-217
-9% -$104K 0.15% 120
2026
Q1 		$1.15M Buy
2,329
+195
+9% +$106K 0.16% 111
2025
Q4 		$1.24M Buy
2,134
+107
+5% +$60.5K 0.2% 96
2025
Q3 		$983K Sell
2,027
-1,286
-39% -$599K 0.17% 117
2025
Q2 		$1.34M Sell
3,313
-62
-2% -$25.9K 0.25% 77
2025
Q1 		$1.68M Buy
3,375
+51
+2% +$27.6K 0.34% 54
2024
Q4 		$1.73M Sell
3,324
-129
-4% -$70.9K 0.34% 54
2024
Q3 		$2.14M Sell
3,453
-100
-3% -$59.2K 0.3% 66
2024
Q2 		$1.97M Buy
3,553
+114
+3% +$65.3K 0.3% 63
2024
Q1 		$2M Buy
3,439
+1,329
+63% +$746K 0.31% 63
2023
Q4 		$1.12M Buy
2,110
+43
+2% +$20.8K 0.19% 99
2023
Q3 		$1.05M Buy
2,067
+20
+1% +$10.7K 0.21% 97
2023
Q2 		$1.07M Buy
2,047
+34
+2% +$18.3K 0.22% 92
2023
Q1 		$1.16M Buy
2,013
+77
+4% +$43.4K 0.24% 81
2022
Q4 		$1.07M Buy
1,936
+1,134
+141% +$601K 0.23% 82
2022
Q3 		$407K Buy
802
+6
+0.8% +$3.36K 0.1% 190
2022
Q2 		$433K Buy
796
+14
+2% +$7.71K 0.1% 182
2022
Q1 		$462K Buy
782
+77
+11% +$44.2K 0.09% 213
2021
Q4 		$470K Buy
705
+92
+15% +$57.4K 0.09% 208
2021
Q3 		$350K Sell
613
-33
-5% -$18.1K 0.07% 251
2021
Q2 		$326K Buy
646
+109
+20% +$51.4K 0.07% 267
2021
Q1 		$245K Buy
537
+12
+2% +$5.73K 0.05% 323
2020
Q4 		$245K Buy
525
+52
+11% +$24.4K 0.06% 300
2020
Q3 		$0 Buy
+473
New +$195K ﹤0.01% 313

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Personal CFO Solutions's TMO Position: Q2 2026 in Review

Personal CFO Solutions reduced its Thermo Fisher Scientific (TMO) stake by 9.3% in Q2 2026, selling an estimated $104K and leaving 2,112 shares worth $1.06M. The position accounts for 0.15% of the portfolio, ranked #120.

Personal CFO Solutions first reported a position in TMO in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.14M in Q3 2024. 2,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Personal CFO Solutions held 2,112 shares of Thermo Fisher Scientific worth $1.06M as of Q2 2026.
  • Personal CFO Solutions sold 217 Thermo Fisher Scientific shares in Q2 2026, an estimated $104K.
  • Thermo Fisher Scientific made up 0.15% of Personal CFO Solutions's portfolio in Q2 2026, its #120 holding.
  • Personal CFO Solutions first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 24 quarters since.
  • Personal CFO Solutions's Thermo Fisher Scientific position peaked at $2.14M in Q3 2024.
  • 2,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Personal CFO Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.